Urea

Urea

SCHEMBL6942597

NC(N)=O.c1ccc(CN2CCNCC2)cc1

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.79
ALDH1A1 P00352 5/20 0.57
KMT2A Q03164 4/20 0.57
MEN1 O00255 2/20 0.57
TSHR P16473 2/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
HIF1A Q16665 1/20 0.57
LMNA P02545 1/20 0.55
CXCR4 P61073 4/20 0.55
CHRM2 P08172 1/20 0.53
CHRM1 P11229 1/20 0.53
ADRA2C P18825 1/20 0.53
CCR2 P41597 1/20 0.53
CXCL12 P48061 1/20 0.53
BLM P54132 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
HRH3 Q9Y5N1 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.51
MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL21981463 0.93 SIGMAR1 (0.85) SIGMAR1ALDH1A1KMT2AMEN1TSHR
Acetic Acid SCHEMBL7452259 0.90 SIGMAR1 (0.79) SIGMAR1ALDH1A1KMT2AMEN1TSHR
SCHEMBL11207245 0.90 SIGMAR1 (0.79) SIGMAR1ALDH1A1KMT2AMEN1TSHR
SCHEMBL152631 0.89 SIGMAR1 (1.00) SIGMAR1ALDH1A1KMT2AMEN1TSHR
SCHEMBL83548 0.89 SIGMAR1 (1.00) SIGMAR1ALDH1A1KMT2AMEN1TSHR
SCHEMBL6138636 0.89 SIGMAR1 (1.00) SIGMAR1ALDH1A1KMT2AMEN1TSHR
SCHEMBL276363 0.89 SIGMAR1 (1.00) SIGMAR1ALDH1A1KMT2AMEN1TSHR
Benzene SCHEMBL27761330 0.89 SIGMAR1 (1.00) SIGMAR1ALDH1A1KMT2AMEN1TSHR
SCHEMBL7573306 0.87 SIGMAR1 (0.96) SIGMAR1ALDH1A1KMT2AMEN1TSHR
SCHEMBL8145866 0.87 SIGMAR1 (0.96) SIGMAR1ALDH1A1KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113292485-A Benzylpiperazine urea TRPV1 antagonistic and MOR agonistic double-target-point medicine, preparation method and application 河南大学 2021-08-24 CN claimed
CN-113292485-B Benzyl piperazine urea TRPV1 antagonizing and MOR agonizing double-target medicine and its prepn and application 河南大学 2023-10-27 CN disclosed
CN-113292485-A Benzylpiperazine urea TRPV1 antagonistic and MOR agonistic double-target-point medicine, preparation method and application 河南大学 2021-08-24 CN disclosed
US-20030087913-A1 Solid pharmaceutical agent formulation for a piperazine urea derivative SCHERING AG (DE) 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087913-A1 Solid pharmaceutical agent formulation for a piperazine urea derivative SLC14A1, UTS2R, SP1 SIGMAR1 386/4885ALDH1A1 1795/4885KMT2A 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.